Leading vaccine manufacturers Moderna, Pfizer, BioNTech and AZ were growing fastest –

Data shows that Covid vaccine manufacturers were the fastest growing pharmaceutical companies in the first three months of this year.

Moderna led the group with sales growth of 221% year-over-year, reaching US$6.1 billion, followed by BioNTech, up 200% to US$6.4, and Pfizer, up 77%, to US$25.7.

AstraZeneca, whose vaccine has been approved in other countries but not in the United States, had the fourth largest revenue increase, up 56% to $11.4.

Activists and charities have accused companies of “disgraceful profits from the pandemic” and described it as “appalling” that few companies are making “obscene money”.

According to data from OurWorldInData, about six in ten people worldwide have received two doses, but in Africa that drops to two out of ten.

There is now an abundant stock of vaccines around the world, but officials in developing countries say many people reject them because they do not see the virus as a threat and are skeptical of vaccines.

This shows the percentage of people doubling in the world (green line) and on different continents. Fewer than two in ten people left with two vaccines in Africa

Maaza Seyoum of the People’s Vaccine Alliance’s Global South Pact, a campaign group calling for equal access to Covid strokes worldwide, told DailyMail.com: “Big pharmaceutical companies have expanded their businesses through an obvious pandemic profit.

“At the height of the crisis, they were selling these life-saving tools to the highest bidder, while people in the global South were left to die.

“And they blocked the technology behind a wall of intellectual property rules and refused to share the recipes with the world.”

A spokesperson for Oxfam, a global anti-poverty charity, told DailyMail.com: . .

“We’ve given these pharmaceutical companies a monopoly of control over the life-saving technology we all need: they control the number of doses they produce, where and at what price they’re sold.”

They choose to prioritize private interests over public health, selling the vast majority of their drugs to rich countries, leaving only what remains to the world’s poor.

“Meanwhile, failing to inoculate the world not only perpetuates suffering, but also puts everyone at risk by allowing new variants to emerge and circulate.”

DailyMail.com looked at total revenue reported by 23 major pharma giants from January to March 2021 and 2022.

The companies behind Covid vaccines recorded the biggest increases in growth.

However, only a five percent increase was seen in Johnson and Johnson, who did not prefer a single dose of Covid vaccine in the USA. It can only be used by people over the age of 18 who will not be able to shoot Moderna or Pfizer as of this month.

Only two giants – Viatris and Biogen – saw their sales fall during the period.

Neither has developed a Covid treatment, but New York-based Viatris is making Pfizer’s Paxlovid pill under a deal.

The list of companies by revenue size shows that the top two Covid vaccine manufacturers are Pfizer, Johnson and Johnson, worth $23.4 billion.

It was followed, among other things, by Roche, which developed an antibody treatment for Covid for $17.2 billion, and Merck, behind the Covid antiviral molnupiravir, for $15.9.

The above shows the number of vaccines distributed (right) and administered (left) in the United States since vaccines were first made available.

Although less than 25% of people worldwide have received booster shots, booster shots have also been distributed in many countries.

Covid vaccines have proven to be a lucrative business early in the pandemic, with countries willing to overpay for safe doses.

Countries initially gave two doses, but last winter many recommended booster vaccines to raise antibody levels.

The United States is now one of the few countries to offer a second booster to anyone over 50.

There are growing signs that another vaccine may be available to the rest of the country this fall, before the winter season when Covid is at its peak.

Pfizer’s vaccines have sold for up to $19.50 per dose in the United States, the BMJ reported, † But while Israel admitted paying $23.50 per dose to get early access, the European Union managed to hit the mark for $. 15.50 each.

The US government helped develop the Moderna jab, which allowed them to be purchased at a discount of $15 each. In contrast, the EU paid $18 per withdrawal.

Johnson & Johnson’s one-time injection sold for about $10 per nonprofit service.

A total of 432 million doses of Pfizer have been distributed in the United States to date, while approximately 274 million doses of Moderna have been distributed. A total of 30 million injections were distributed for the Johnson and Johnson vaccine.

Rahab Mwaniki, Africa coordinator of PVA, explained why the spread of Kovid in Africa is low, saying that he wanted people there to be hit when the number of cases on the continent is low.

“A lot of people say, ‘You didn’t help us,'” he told Reuters. “They think the West has never really supported them.”

DailyMail.com reached out to Moderna, Pfizer, BioNTech and AstraZeneca for comment.